3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 17.94

Change

-0.05 (-0.28)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.64 (+2.80%)

USD 161.07B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+2.40 (+2.97%)

USD 20.18B
2801:HK iShares Core MSCI China ETF

+0.32 (+1.31%)

USD 17.71B
2823:HK iShares FTSE A50 China

+0.43 (+2.67%)

USD 14.19B
83188:HK ChinaAMC CSI 300 Index ETF

+1.50 (+3.28%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.07 (+5.04%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.61 (+5.84%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.41 (+2.98%)

USD 7.65B
9010:HK iShares Core MSCI AC Asia ex J..

+0.08 (+1.03%)

USD 3.03B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.10% 48% F 54% F
Dividend Return 1.73% 23% F 16% F
Total Return 8.84% 49% F 53% F
Trailing 12 Months  
Capital Gain 15.74% 58% F 62% D
Dividend Return 1.87% 22% F 16% F
Total Return 17.61% 59% D- 62% D
Trailing 5 Years  
Capital Gain 52.55% 79% B- 82% B
Dividend Return 8.16% 61% D- 26% F
Total Return 60.71% 79% B- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.68% N/A N/A 74% C
Dividend Return 10.81% N/A N/A 72% C
Total Return 1.13% N/A N/A 26% F
Risk Return Profile  
Volatility (Standard Deviation) 12.85% N/A N/A 88% B+
Risk Adjusted Return 84.14% N/A N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike